iPS cell induction by bromodeoxyuridine: Shanghai Insstitute of Materia Medica

The group of Xin XIE at Shanghai Institute of Materia Medica has found that bromodeoxyuridine can replace Oct4 in mouse embryonic fibroblasts, the most critical factor in the „Yamanaka factors“ used for cell reprogramming.

CAS news release, August 19, 2015

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny